NIH Director’s Wednesday Afternoon Lecture Series

Human pluripotent stem cells in understanding genetic cardiovascular disease and effects of drugs

Derivation of many different cell types from human pluripotent stem cells (embryonic stem cells or HESCs and induced pluripotent stem cells or hiPS cells) is an area of growing interest both for potential cell therapy and as a platform for drug discovery and toxicity.

Therapy of lymphoma inspired by functional and structural genomics

Dr. Staudt pioneered the use of gene expression profiling to discover molecularly and clinically distinct cancer subtypes and to predict response to therapy. He defined molecular subtypes of lymphoma that were previously unrecognized but are now viewed as distinct diseases that arise from different stages of B cell differentiation, utilize different oncogenic mechanisms and offer new therapeutic targets.

Lecture Title Forthcoming

The information for this lecture has not yet been made available. Please check back soon for an updated overview.